Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 5617

Sort by

Sort Order Select

Journal Articles

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study

Blood Adv (2025) 9 (24): 6292–6304.

https://doi.org/10.1182/bloodadvances.2024015787

Published: 2025

Includes: Supplemental data

Journal Articles

Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease

Yvette C. Tanhehco, Suzanne Thibodeaux, Patricia A. Shi, Stella T. Chou, Shannon A. Kelly, Grace Fortes Monis, Carly Newton, Kamille West-Mitchell, Yan Zheng, Christine Fernandez, Christina Anderson, Kimberly Ching, Victoria Coleman-Cowger, Adrienne Shapiro, John P Manis

Blood Adv (2025) 9 (24): 6524–6533.

https://doi.org/10.1182/bloodadvances.2025016054

Published: 2025

Journal Articles

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

Samira Glaeser-Khan, Satoko Ito, Manraj Sra, Rhys Richmond, Robert D. Bona, Harlan M. Krumholz, Stacy E. Croteau, Adam Cuker, George Goshua

Blood Adv (2025) 9 (24): 6237–6245.

https://doi.org/10.1182/bloodadvances.2025016822

Published: 2025

Includes: Supplemental data

Journal Articles

A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model

Dorottya Laczko, Patricia Tsao, Ruth-Anne Pai, Joseph Zinski, Michael V. Gonzalez, Melanie D. Mumau, Tobias Raabe, Hiromi Muramatsu, Norbert Pardi, Taku Kambayashi, David C. Fajgenbaum

Blood Adv (2025) 9 (24): 6534–6537.

https://doi.org/10.1182/bloodadvances.2025016749

Published: 2025

Includes: Supplemental data

Journal Articles

Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel

Akshay Sharma, Franco Locatelli, Monica Bhatia, Lyndsay Molinari, Markus Y. Mapara, Robert I. Liem, Laurence Dedeken, Donna Wall, Michael J. Eckrich, Kevin H. M. Kuo, Wally Smith, Suzan Imren, Puja Kohli, Nanxin Li, Tina Liu, Jaime Rubin, William Hobbs, Stephan A. Grupp, Haydar Frangoul

Blood Adv (2025) 9 (24): 6481–6490.

https://doi.org/10.1182/bloodadvances.2025016701

Published: 2025

Includes: Supplemental data

Journal Articles

Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcel

Blood Adv (2025) 9 (24): 6502–6510.

https://doi.org/10.1182/bloodadvances.2025016702

Published: 2025

Includes: Supplemental data

Journal Articles

USP7 alterations are associated with a poor survival in pediatric T-cell acute lymphoblastic leukemia

Unai Illarregi, Angela Gutierrez-Camino, Ricardo Lopez-Almaraz, Javier Arzuaga-Mendez, Manuel Ramirez-Orellana, Emily Ashcraft, Daniel Sinnett, Itziar Astigarraga, Idoia Martin-Guerrero, Elixabet Lopez-Lopez

Blood Adv (2025) 9 (24): 6404–6409.

https://doi.org/10.1182/bloodadvances.2025017219

Published: 2025

Includes: Supplemental data

Journal Articles

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma

Rudra Prasad Dutta, Heng-Huan Lee, Violetta V. Leshchenko, Ravi Prakash Shukla, Fangfang Yan, Yang Liu, H. Ümit Kaniskan, Xing Qiu, Jian Jin, Lapo Alinari, Michael Wang, Samir Parekh

Blood Adv (2025) 9 (24): 6267–6278.

https://doi.org/10.1182/bloodadvances.2025016801

Published: 2025

Includes: Supplemental data

Journal Articles

Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going

Elena Zamagni, Marco Talarico

Blood Adv (2025) 9 (24): 6252–6266.

https://doi.org/10.1182/bloodadvances.2024015686

Published: 2025

Journal Articles

Monoclonal gammopathy defines distinct clinical subsets in chronic lymphocytic leukemia across therapeutic eras

Yuting Yan, Bolin Yuan, Tonglu Qiu, Guoqiang Liu, Weihao Chen, Tingyu Wang, Ying Yu, Wenjie Xiong, Gang An, Dehui Zou, Jianyong Li, Liang Wang, Shuhua Yi

Blood Adv (2025) 9 (24): 6279–6291.

https://doi.org/10.1182/bloodadvances.2025017057

Published: 2025

Includes: Supplemental data

Journal Articles

Critical role of niche S100A8 for acute myeloid leukemia progression and hematopoiesis regeneration

Xiaoyan Liu, Jinxian Wu, Xinqi Li, Ruiyang Pan, Li Liu, Tingting Huang, Linlu Ma, Guopeng Chen, Qian Wang, Nan Zhang, Xiqin Tong, Yuxin Tan, Hongqiang Jiang, Yuxing Liang, Min Shen, Ruihang Li, Wanyue Yin, Xian Zhang, Fuling Zhou

Blood Adv (2025) 9 (24): 6575–6589.

https://doi.org/10.1182/bloodadvances.2024015762

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Ramón García-Sanz, Roger G. Owen, Wojciech Jurczak, Meletios A. Dimopoulos, Helen McCarthy, Gavin Cull, Stephen S. Opat, Jorge J. Castillo, Marie José Kersten, Björn E. Wahlin, Sebastian Grosicki, Radha Prathikanti, Tian Tian, Heather Allewelt, Aileen Cleary Cohen, Constantine S. Tam

Blood Adv (2025) 9 (24): 6538–6546.

https://doi.org/10.1182/bloodadvances.2024015596

Published: 2025

Journal Articles

Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myeloma

Maria Teresa Bilotta, Antonio Giovanni Solimando, Vanessa Desantis, Lucia Di Marzo, Andrea Sabatini, Sergio Forcelloni, Alessandro Andriano, Arcangelo Morizio, Antonella Argentiero, Roberto Ria, Linda Quatrini, Lorenzo Moretta, Paola Vacca, Nicola Tumino

Blood Adv (2025) 9 (24): 6246–6251.

https://doi.org/10.1182/bloodadvances.2025016659

Published: 2025

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Blood Adv (2025) 9 (24): 6314–6325.

https://doi.org/10.1182/bloodadvances.2025017084

Published: 2025

Includes: Supplemental data

Journal Articles

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Pooja Khandelwal, Azada Ibrahimova, Adam Lane, Michael Grimley, Stella M. Davies, Sonata Jodele

Blood Adv (2025) 9 (24): 6370–6379.

https://doi.org/10.1182/bloodadvances.2025017197

Published: 2025

Includes: Supplemental data

Journal Articles

Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma

Blood Adv (2025) 9 (24): 6443–6454.

https://doi.org/10.1182/bloodadvances.2025016827

Published: 2025

Includes: Supplemental data

Journal Articles

Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis

Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles, Jessica M. Stempel, Alain Mina, Lourdes Mendez, Tariq Kewan, Nikolai A. Podoltsev, Maximilian Stahl, Alyssa A. Grimshaw, Amer M. Zeidan, Jan Philipp Bewersdorf

Blood Adv (2025) 9 (24): 6511–6523.

https://doi.org/10.1182/bloodadvances.2025017611

Published: 2025

Includes: Supplemental data

Journal Articles

Androgen receptor signaling as a new target for intervention in acute myeloid leukemia

Fenghua Qian, Deborpita Sarkar, Brooke E. Arner, Vanessa M. Peduzzi, Yuting Bai, Baiye Ruan, Bei Jia, Hong Zheng, Robert F. Paulson, K. Sandeep Prabhu

Blood Adv (2025) 9 (24): 6326–6339.

https://doi.org/10.1182/bloodadvances.2024012639

Published: 2025

Includes: Supplemental data

Journal Articles

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

Bhavna Bhasin-Chhabra, Tao Wang, John E. Levine, Shalini Shenoy, Miguel-Angel Perales, Asad Bashey, Hershel Raff, Wael Saber

Blood Adv (2025) 9 (24): 6394–6401.

https://doi.org/10.1182/bloodadvances.2025016655

Published: 2025

Includes: Supplemental data

Journal Articles

In situ gene editing of hematopoietic stem cells via AAV-delivered CRISPR guide RNAs

Alborz Karimzadeh, Rebekah Kim, Vivian Garcia, Michael Florea, Bryan L. Peacker, Shio Kobayashi, Drake Watkins, Kathleen Messemer, Jing Zeng, Daniel E. Bauer, Thomas Serwold, Amy J. Wagers

Blood Adv (2025) 9 (24): 6563–6574.

https://doi.org/10.1182/bloodadvances.2025016775

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study

Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model

Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel

Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcel

USP7 alterations are associated with a poor survival in pediatric T-cell acute lymphoblastic leukemia

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma

Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going

Monoclonal gammopathy defines distinct clinical subsets in chronic lymphocytic leukemia across therapeutic eras

Critical role of niche S100A8 for acute myeloid leukemia progression and hematopoiesis regeneration

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myeloma

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma

Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis

Androgen receptor signaling as a new target for intervention in acute myeloid leukemia

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

In situ gene editing of hematopoietic stem cells via AAV-delivered CRISPR guide RNAs

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only